Login / Signup

Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.

David J Kuter
Published in: Journal of internal medicine (2023)
Keyphrases
  • metastatic colorectal cancer
  • drug induced